Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis. by Jiajie Zang, Shunquan Wu, Lei Tang, Xudong Xu, Jie Bai, Caicui Ding, Yue Chang, Long Yue, Enming Kang, Jia He

Get full text

Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase... by Jingyi Li, Yunsheng Liang, Wenli Feng, Liehua Deng, Hong Fang, Chao Ji, Youkun Lin, Furen Zhang, Rushan Xia, Chunlei Zhang, Shuping Guo, Mao Lin, Yanling Li, Shoumin Zhang, Xiaojing Kang, Liuqing Chen, Zhiqiang Song, Xu Yao, Chengxin Li, Xiuping Han, Guoxiang Guo, Qing Guo, Xinsuo Duan, Jie Li, Juan Su, Shanshan Li, Qing Sun, Juan Tao, Yangfeng Ding, Danqi Deng, Fuqiu Li, Haiyun Suo, Shunquan Wu, Jingbo Qiu, Hongmei Luo, Linfeng Li, Ruoyu Li, Lishao Guo

Get full text